Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lorena Bellido-Hernández"'
Autor:
Luis Posado-Domínguez, María Escribano-Iglesias, Lorena Bellido-Hernández, Johana Gabriela León-Gil, María Asunción Gómez-Muñoz, Felipe Gómez-Caminero López, María Martín-Galache, Sandra M. Inés-Revuelta, Emilio Fonseca-Sánchez
Publikováno v:
Current Oncology, Vol 31, Iss 11, Pp 7319-7329 (2024)
Summary: Anti PD1/PD-L1 agents, including pembrolizumab, have revolutionized the oncological treatment of different types of cancer, including non-small cell lung cancer. The most frequent complications associated with this type of treatment are mild
Externí odkaz:
https://doaj.org/article/7277a82e1c3d460f80f4c8f6dab4c204
Autor:
Eduardo Terán Brage, Jonnathan Roldán Ruíz, Juan Diego Oviedo Rodríguez, Rosario Vidal Tocino, Sara Rodríguez Diego, Pedro Luis Sánchez Hernández, Lorena Bellido Hernández, Emilio Fonseca Sánchez
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 6, Iss , Pp 100153- (2022)
Introduction COVID-19 disease has caused a global health and economic crisis. The introduction of the different COVID-19 vaccines has resulted in a significant decrease in the morbidity and mortality associated with this disease. Adverse effects have
Externí odkaz:
https://doaj.org/article/357e4ff4aa99446683f8e41774ed343a
Autor:
Alejandro Olivares-Hernández, Luis Figuero-Pérez, María A. Amores Martín, Lorena Bellido Hernández, Laura Mezquita, María del Rosario Vidal Tocino, Félix López Cadenas, Felipe Gómez-Caminero López, Roberto A. Escala-Cornejo, Juan Jesús Cruz Hernández
Publikováno v:
Case Reports in Oncological Medicine, Vol 2021 (2021)
Background. Immunotherapy represents one of the fundamental treatments in the management of some types of cancer, especially malignant melanoma. Toxicity derived from increased immune system activity can manifest in multiple organs and systems. We pr
Externí odkaz:
https://doaj.org/article/b19b5de9bf6040fb823aa05576db61a9
Autor:
Alejandro Olivares-Hernández, Edel del Barco Morillo, José Pablo Miramontes-González, Luis Figuero-Pérez, Luis Pérez-Belmonte, Javier Martín-Vallejo, Teresa Martín-Gómez, Roberto Escala-Cornejo, Rosario Vidal-Tocino, Lorena Bellido Hernández, Rogelio González Sarmiento, María Dolores Ludeña de la Cruz, Juan Jesús Cruz-Hernández, Carmen Parra Pérez
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 27, Iss 3, p 088 (2022)
Background: Determining predictive biomarkers for immune checkpoint inhibitors (ICIs) is a current challenge in oncology. Previous studies on non-small cell lung cancer (NSCLC) have shown how TP53 gene mutations are correlated with different response
Externí odkaz:
https://doaj.org/article/2e875689dc294cbd9ee53e52fef53475
Autor:
Alejandro Olivares-Hernández, Edel del Barco Morillo, Carmen Parra Pérez, José Pablo Miramontes-González, Luis Figuero-Pérez, Teresa Martín-Gómez, Roberto Escala-Cornejo, Lorena Bellido Hernández, Rogelio González Sarmiento, Juan Jesús Cruz-Hernández, María Dolores Ludeña de la Cruz
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 360 (2022)
Mutations in the mismatch repair (MMR) system predict the response to immune checkpoint inhibitors (ICIs) like colon or gastric cancer. However, the MMR system’s involvement in non-small cell lung cancer (NSCLC) remains unknown. Addressing this iss
Externí odkaz:
https://doaj.org/article/5de62e725be94de185c7f8f23f0eb928
Autor:
Félix López Cadenas, Laura Mezquita, María A Amores Martín, Roberto A. Escala-Cornejo, Luis Figuero-Pérez, Juan Jesús Cruz Hernández, Felipe Gómez-Caminero López, María Del Rosario Vidal Tocino, Alejandro Olivares-Hernández, Lorena Bellido Hernández
Publikováno v:
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine, Vol 2021 (2021)
Case Reports in Oncological Medicine, Vol 2021 (2021)
Background. Immunotherapy represents one of the fundamental treatments in the management of some types of cancer, especially malignant melanoma. Toxicity derived from increased immune system activity can manifest in multiple organs and systems. We pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f24bcca54d27c85e7c4133643d12ec72
https://doi.org/10.1155/2021/6631859
https://doi.org/10.1155/2021/6631859
Autor:
Carmen Parra Pérez, Juan Jesús Cruz-Hernández, María Dolores Ludeña de la Cruz, Rogelio González Sarmiento, Lorena Bellido Hernández, Rosario Vidal-Tocino, Roberto Escala-Cornejo, Teresa Martín-Gómez, Javier Martín-Vallejo, Luis Pérez-Belmonte, Luis Figuero-Pérez, José Pablo Miramontes-González, Edel del Barco Morillo, Alejandro Olivares-Hernández
Publikováno v:
Frontiers in bioscience (Landmark edition). 27(3)
Determining predictive biomarkers for immune checkpoint inhibitors (ICIs) is a current challenge in oncology. Previous studies on non-small cell lung cancer (NSCLC) have shown how TP53 gene mutations are correlated with different responses to ICIs. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34cd47e5a6337adb71f38a54d74fa90
https://pubmed.ncbi.nlm.nih.gov/35345320
https://pubmed.ncbi.nlm.nih.gov/35345320
Autor:
Natalia García-Sancha, Esther Cardeñoso-Alvarez, Jesús Pérez-Losada, Lorena Bellido-Hernández, Javier Cañueto, Concepción Román-Curto, Roberto Corchado-Cobos, Alberto Orfao
Publikováno v:
Cancers, Vol 13, Iss 5134, p 5134 (2021)
Cancers
Cancers
© 2021 by the authors.
Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans, and is now responsible for as many deaths as melanoma. Immunotherapy has changed the therapeutic landscape of advanced CSCC after the
Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans, and is now responsible for as many deaths as melanoma. Immunotherapy has changed the therapeutic landscape of advanced CSCC after the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3691c2663e942c0cf2a7195a2ecfb3aa
https://doi.org/10.3390/cancers13205134
https://doi.org/10.3390/cancers13205134
Autor:
Lorena Bellido Hernández
Publikováno v:
GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
instname
[ES]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7abb24c549cce8cccfb601ece6c2fc2
http://hdl.handle.net/10366/140366
http://hdl.handle.net/10366/140366
